| Serial Number | 98107200 |
| Word Mark | STUDY MARKETPLACE |
| Filing Date | Friday, July 28, 2023 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 21, 2025 |
| Registration Number | 7665078 |
| Registration Date | Tuesday, January 21, 2025 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the words STUDY MARKETPLACE in upper case with the first "E" being stylized, consisting of a lowercase letter "E" in stylized font wherein the horizontal bar of the letter "E" is formed by a line extending beyond the outer edge of the "E". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Business consulting and management in the field of clinical trials, namely, providing business information management services; Providing operational business development assistance to clinical research sites of others; conducting business feasibility studies; providing business development services to a network of investigation sites and providing independent review of clinical trials for business purposes through a network of investigational sites; Patient recruitment, retention, and marketing services, namely, operation of telephone call center, development of advertising and marketing materials for others, developing and support of recruitment and marketing plans for patient outreach in the nature of posting of clinical trial notices for the purpose of recruiting patients for participating in clinical trials for the testing of drugs, and advertising services, namely, management of print media and online advertising campaigns to recruit patients, and business management services for clinical studies conducted by others |
| Goods and Services | Providing temporary use of online non-downloadable user interface software that enables users to enter, access, track, monitor and generate health and medical information and reports and enable users to measure and manage mobile clinical activities and patient health status in clinical trials and other health monitoring regimes; providing temporary use of online non-downloadable user interface software for clinical trials and other health monitoring regimes for use in a collaborative form with multiple users for sharing purposes, for patient information, including patient reported outcomes, entry and capture and data entry and capture, for patient-related information management and data management, for issue management and risk management; providing temporary use of online non-downloadable user interface software for clinical trials and other health monitoring regimes for task management, note-taking, messaging, connecting users, and task delegation between users; providing temporary use of online non-downloadable user interface software for the tracking and management of patients, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; providing temporary use of online non-downloadable user interface software for use by medical professionals, allied health professionals and service providers, and patients to capture and organize patient information, including patient reported outcomes; providing temporary use of online non-downloadable user interface software for use in aggregating, integrating, analyzing, standardizing, managing and reporting of data in clinical trials, clinical data, financial data, and electronic medical records data; providing temporary use of online non-downloadable user interface software for the purpose of aggregating and analyzing patient data; providing temporary use of online non-downloadable user interface software that enables users to control and manage patient medical information; providing temporary use of online non-downloadable user interface software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information regarding electronic health records of individuals; providing temporary use of online non-downloadable user interface software for providing patient education information; providing temporary use of online non-downloadable user interface software that enables streamlined collection of electronic patient source data, tracking of clinical trial management activity, and financial management of clinical studies |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 28, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, November 21, 2021 |
| First Use In Commerce Date | Monday, October 7, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 28, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, November 21, 2021 |
| First Use In Commerce Date | Monday, October 7, 2024 |
| Party Name | Elligo Health Research, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Austin, TX 78738 |
| Party Name | Elligo Health Research, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Austin, TX 78738 |
| Event Date | Event Description |
| Wednesday, April 10, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 10, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, April 10, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 21, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, June 21, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, August 1, 2023 | NEW APPLICATION ENTERED |
| Monday, August 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
| Thursday, October 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 10, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Thursday, October 10, 2024 | USE AMENDMENT FILED |
| Wednesday, October 16, 2024 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, October 16, 2024 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, October 16, 2024 | TEAS AMENDMENT OF USE RECEIVED |
| Wednesday, October 16, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, October 16, 2024 | USE AMENDMENT FILED |
| Wednesday, October 16, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Tuesday, November 19, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, November 19, 2024 | FINAL REFUSAL WRITTEN |
| Tuesday, November 19, 2024 | USE AMENDMENT ACCEPTED |
| Tuesday, November 19, 2024 | USE AMENDMENT ACCEPTED |
| Tuesday, November 19, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, October 10, 2024 | TEAS AMENDMENT OF USE RECEIVED |
| Sunday, October 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 18, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, December 18, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, December 18, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, December 18, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, December 19, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 19, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, December 27, 2024 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Tuesday, January 21, 2025 | REGISTERED-SUPPLEMENTAL REGISTER |
| Tuesday, January 21, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |